Tweedy Browne is an investment partnership owned by its four managing directors. Investments are focused in developed markets, and where practicable, perceived foreign currency exposure is hedged back into the U.S. dollar. The fund is a pure no-load fund with no 12b-1 provisions. The fund is managed by the team of Tweedy Browne (Trades, Portfolio) Partners.
The portfolio is composed of 47 stocks. Total value of the portfolio is $3.705 Mil and the following three stocks are the companies that have the highest yield and is growing more than other stocks held by the Guru.
ConocoPhillips (COP)
COP has a dividend yield of 4.29% and a payout ratio of 92%. The yield is growing steadily at a rate of 11.50% over the last 10 years, and 7.90% over the last 5 years.
The company is engaged in exploring for, developing and producing crude oil and natural gas. It has a market cap of $82.82 B and is now trading at 16.60 of P/E +10.90%Â from its 52-Week Low and -22.87%Â from its 52-week high. Over the past 12 months, the price dropped by -14%. Despite the low P/E, the DCF model, with a suggested fair value of $46.32 says the stock is overpriced by 45%
Over the last five years, the company's revenue dropped by 18.60%, EBITDA grew by 0.60% and EPS growth rate is 5.40% . Profitability & growth is rated 4/10 and COP has positive returns (9.49% of ROE, 4.27% of ROA and 7.91% of ROC) and these returns are ranked higher than 87% of other companies in the Global Oil & Gas E&P industry.
James Barrow is the bigger holder of COP (he holds 1.94% of Shares Outstanding), followed byJean–Marie Eveillard (holding 7,735,877 shares or 0.63% of outstanding shares) and Donald Yacktman (holding 5,970,958 shares or 0.48% of outstanding shares).
GlaxoSmithKline PLC (GSK)
GSK has a dividend yield of 5.73% with a reasonable payout of 38%. The growth rate is 6.70% over the last 5 years and 7.70 over the last 10 years. During the last 12 months, the ratio declined by 4.90% so before taking any decision, it may be better to wait the near future so see how things will go.
The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products. It has a market cap of $110.9 Billion and its shares are now trading with a P/E(ttm) of 7.10 and the price is now +11.38% from its 52-Week Low and -17.37% from its 52-week high. Over the past 12 months, the price dropped by 17%.
The DCF model, gives a fair value of $93.93 and this rating put the stock as undervalued and trading with a margin of safety of 51%.
Over the last five years, the company's revenue dropped by 2.50%, EBITDA by 5.10%. Profitability & Growth is rated 5/10 and GSK has positive returns (172.64% of ROE, 23.39% of ROA and 125.05% of ROC) and they are ranked higher than 97% of other companies in the Global Drug Manufacturers – Major industry.
Dodge & Cox is the bigger holder of GSK (he holds 0.89% of Shares Outstanding), followed by HOTCHKIS & WILEY (holding 12,213,885 shares or 0.46% of outstanding shares) and Ken Fisher holding 10,757,080 shares or 0.4% of outstanding shares.
Exxon Mobil Corporation (XOM)
XOM has a dividend yield of 3.10 % with a payout ratio of 41%. The yield has a growth rate of 9.60% over the last 10 years and 10.90% over the last 5 years.
The Company has a market cap of $364.38 billion and its main business is energy, involving exploration for, and production of, crude oil and natural gas, manufacture of petroleum products and transportation and sale of crude oil, natural gas and petroleum products.
The stock is currently trading at 13.40 of P/E +5.96% from its 52-Week Low and -16.37% from its 52-week high. Over the past 12 months, the price dropped by15%.
The DCF model, gives a fair value of $71.62 that put the stock as overpriced by 22%Â at current prices.
Over the last five years, the company's revenue rose by 8.30%, EBITDA grew by 9.70% and EPS growth rate was 11.70%. Profitability & Growth is rated 8/10, since XOM has positive returns (16.04% of ROE, 8.07% of ROA and 17.15% of ROC) and these returns are ranked higher than 94% of other companies in the Global Oil & Gas Integrated industry.
Donald Yacktman is the bigger holder of XOM (he holds 0.17% of Shares Outstanding), followed by Brian Rogers(holding 5.414,200 shares or 0.13% of outstanding shares) and Ken Fisher who holds 4,428,735 shares or 0.11% of outstanding shares.
